H4C7: Potential Drug Target Or Biomarker (G8369)

Target Name: H4C7

NCBI ID: G8369

H4C7

H4C7: Potential Drug Target Or Biomarker

H4C7, also known as HIST1H4G, is a protein that is expressed in various tissues throughout the body. It is a member of the histone family, which is a group of small non-coding RNAs that play a critical role in the regulation of gene expression. H4C7 has been shown to be involved in a number of cellular processes, including cell division, apoptosis, and tissue repair. As a result, H4C7 has potential as a drug target or biomarker.

One of the key functions of H4C7 is its role in cell division. During the G1 phase of the cell cycle, H4C7 is expressed in the nuclei of actively dividing cells and is involved in the maintenance of DNA replication and gene expression. In addition, H4C7 has been shown to play a role in the regulation of cell division in cancer cells. For example, studies have shown that H4C7 expression is associated with poor prognosis in breast cancer and that inhibition of H4C7 has been shown to improve survival in these patients.

Another function of H4C7 is its role in apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. H4C7 is involved in the regulation of apoptosis, and has been shown to play a role in the regulation of cell death. For example, studies have shown that H4C7 is involved in the regulation of apoptosis in neurodegenerative diseases, including Alzheimer's disease. In addition, H4C7 has been shown to play a role in the regulation of apoptosis in cancer, by promoting the apoptosis of cancer cells.

In addition to its role in cell division and apoptosis, H4C7 is also involved in the regulation of tissue repair. During wound healing, H4C7 is expressed in the nuclei of actively dividing cells and is involved in the regulation of cell proliferation and differentiation. In addition, H4C7 has been shown to play a role in the regulation of tissue repair in wound healing, by promoting the growth and proliferation of cells that are involved in tissue repair.

Due to its involvement in a number of cellular processes, H4C7 has potential as a drug target or biomarker. For example, studies have shown that H4C7 can be targeted with small molecules, such as inhibitors of the H4C7 enzyme, to enhance the regulation of cell division and apoptosis. In addition, H4C7 has been shown to be involved in the regulation of apoptosis in cancer, and inhibition of H4C7 has been shown to improve survival in these patients.

Overall, H4C7 is a protein that is involved in a number of cellular processes that are important for cell survival and growth. As a result, H4C7 has potential as a drug target or biomarker, and further research is needed to fully understand its role in these processes.

Protein Name: H4 Clustered Histone 7

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling (By similarity)

The "H4C7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H4C7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets